Navigation Links
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
Date:8/7/2009

NEW YORK, Aug. 7 /PRNewswire-Asia-FirstCall/ --


            --2Q09 Revenue Increased 20.7% YoY to $71.2 Million--

--2Q09 Net Income Attributable to Controlling Interest was $13.2 million or

                          $0.17 per Diluted Share--

   -- Company Generates Approximately $22.9 Million of Operating Cashflow--

American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, today announced financial results for the second quarter ended June 30, 2009.

Revenue in the second quarter of 2009 increased 20.7% to $71.2 million from $59.0 million in the second quarter of 2008, reflecting continued demand for the Company's core pharmaceutical and nutraceutical products. Revenue from pharmaceutical products increased 17.4% to $58.4 million from $49.8 million in the prior year's second quarter. Revenue from prescription pharmaceutical products increased 23.2% to $25.2 million during the second quarter of 2009, reflecting an increase in sales from prescription formulation Jinji and CCXA products, which offset declines in sales of Shuanghuanglian Injection Powder ("SHL"). OTC pharmaceutical products generated $33.3 million in revenue during the second quarter of 2009, up from $29.4 million in the prior year's period, reflecting continued demand for Boke and GLP products, as a result of marketing efforts and improved recognition of the products. Nutraceutical products generated revenue of approximately $9.5 million in the second quarter of 2009, up 3.3% from $9.2 million in the prior year's period, reflecting increased sales of new beverage products launched in the begin
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... METTLER TOLEDO recently announced that a free web...on Using At-Line Particle Characterization”,...ebinar, the application of in situ particle charac... and optimize a series of roller compaction runs w... compaction forces. , (PR...
(Date:11/19/2009).... 19 Danish Prince Joachim inaugur...l plant in Kalundborg, Denmark, on Wednesday, Nove...and largest 2nd generation ethanol demonstration b...sed in the plant,s innovative process for converti... was the first to market with commercial enzymes f...
(Date:11/19/2009)...THESDA, Md., Nov. 19 Sph...n biotechnology for diabetes therapy, and a provid... to food, supplement, biotechnology and pharmaceut...iously reported $6.3 million registered direct pla...res of its common stock and warrants to purchase u...
(Date:11/19/2009)...a. and WALTHAM, Mass., Nov. 19 Arl...ces find that the leading driver of antibiotic sel...spectrum activity against gram-positive and gram-n... that can cause nosocomial pneumonia, surveyed Eur...or agents that provide appropriate coverage agains...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...l to be Held on October 16th, SAN DIEGO, Oct. 10 ...at the company will release its fourth quarter and...15, 2008, and will,subsequently host a conference ...:30 PM ET. The conference call will consist of pre...e over the Internet via live,web cast at http://w...
... Oct. 10 Wyeth (NYSE: WYE ),announced today that...ly,and as Administrator of the Estate of Edna Faye...mmon Pleas found in favor of Wyeth., "We believe ...ce," says,Bob Nicholas, an attorney from Reed Smit...ath was tragic, the medical evidence clearly demon...
...alif., Oct. 10 Finesse Solutions, LLC,Santa Clara...lutions for,life science process applications, ann...oreactor control software. TruBio 3.4 software can...lications, ranging from 1L bench,top R&D glass to ....4,software is optimized for DeltaV version 9.3 fr...
Other Biology Technology:PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 2Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software 2
(Date:11/20/2009)...a research report published in the November 2009 i...cs.org ), scientists show how a family of genes (1...genes) are responsible for production of ethylene....t, and this information lays the foundation for fu...isease resistant, able to survive and thrive in di...
(Date:11/20/2009)...earchers are invited to contribute their abstracts...CO ECCEO10), the largest global meeting devoted t...esearch and patient care. The Congress will be hel...ning today, abstracts can be submitted online at ... deadline is February 4, 2010. , IOF and ESCEO a...
(Date:11/20/2009)..., Toxic dust: Toxins in coal-tar-based sealcoats...d house dust, according to a USGS study. PAHs or...ules found in oil, coal and tar deposits, and can ... are often found in house dust; however, the speci.... Researchers found that dust from indoor areas ne...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Study points to new uses unexpected side effects of already existing drugs 10627 1Study points to new uses unexpected side effects of already existing drugs 10627 2Avantpage Celebrates Its 26quot 3BLucky 13th 26quot 3B Anniversary with Report on Recent History Emerging Trends in Translation 60673 1Avantpage Celebrates Its 26quot 3BLucky 13th 26quot 3B Anniversary with Report on Recent History Emerging Trends in Translation 60673 2Focused Radiation May Help Some With Lung Cancer 60671 1Focused Radiation May Help Some With Lung Cancer 60671 2
...ublished in the journal Soil Use and Management ...and severity of land degradation across the globe ...ng often in very productive areas. , Land degrad...and vegetation is of profound importance but unti... which to assess its extent and severity. For near...
...Institute of Technology have used a new approach, ...f the bacterium that causes anthrax, Bacillus anth...ine by the Journal of Bacteriology , marks the fi...ollection of mRNAs produced by a bacterium as it e...efined, and provides a much more detailed view of ...
... 20, 2009 Ecopsychologyan emerging field that exp... issues and ways in which ecology and psychology i...is the focus of a new online peer-reviewed journal... Ann Liebert, Inc. this spring ( www.liebertpub.co...ionship between environmental issues and mental he...
Other Biology News:A quarter of the world's population depends on degrading land 2New technique used to profile anthrax genome 2New technique used to profile anthrax genome 3New ecopsychology journal will premiere in spring 2009 2
Rabbit Anti-Human SCNN1A Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rat Anti-Mouse F4 / 80 Antigen Monoclonal Antibody, Biotin Conjugated from AbD Serotec
Rabbit Anti-Bacterial HISTIDASE Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-AMPHOTERIN Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: